Leiden, The Netherlands — Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim of the project is to improve existing neurotoxicity tests and to reduce experimentation on animals. A panel of experts from BASF, Sanofi, GlaxoSmithKline, Abbvie, NC3Rs and renowned academic institutions has selected […]
WASHINGTON — Ahead of an investor and analyst meeting to be held in New York, Danaher Corporation (NYSE: DHR) (the “Company”) reaffirmed the Company’s adjusted diluted net earnings per share guidance of $1.25 to $1.29 for the fourth quarter 2015. The Company anticipates that 2016 adjusted diluted net earnings per share will be in the […]
Seoul, Korea – Park Systems, world-leader in atomic force microscopy (AFM) officially announced 1 million shares for its initial public offering on December 17th at KOSDAQ, which is a Korean version of NASDAQ, established in 1996 to be a capital supplier of venture and small and medium-sized businesses. The underwriter of the company is KB […]
Oxford and Cambridge, UK – Oxford Gene Technology (OGT), the molecular genetics company, has continued its impressive sales performance and has refocused its business to take advantage of the significant growth potential in the global genomics market. Commercial and financial highlights for the year ended 30 September show the company delivering £14.3m sales revenues on […]
Darmstadt, Germany – Merck, a leading science and technology company, today informed analysts and investors at its 2015 Capital Market Day about the strategic priorities that will influence its operating result in 2016. The integration of Sigma-Aldrich as well as the further development of the pharmaceutical pipeline are at the top of the list. Apart […]
LONDON & SAN DIEGO — Desktop Genetics Ltd (“DTG” or “the Company”), a software company revolutionizing the way biologists use CRISPR gene editing technology, announced today that it has received investment funding fromIllumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing (NGS) technology. The investment will be used to fund the continued development and […]
SAN FRANCISCO — Illumina, Inc. (NASDAQ:ILMN) announced today that Illumina Accelerator–the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry–has selected four new investments from a competitive pool of highly qualified applicants to be a part of its third funding cycle. “Illumina Accelerator is pleased to have such a […]
Rights issue and development loan fund expansion in software team and US salesforce Qlucore, a world leader in the development of bioinformatics software enhances its financial position with a combination of a rights issue and a development loan from Swedish regional development fund ALMI. Investment from the two sources is EURO 545,000. This injection of […]
SOUTH EASTON, Mass. — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of broadly enabling, pressure cycling technology (“PCT”)-based sample preparation solutions to the worldwide life sciences industry, today announced it has received gross proceeds of $745,000 from an additional closing of its $5 million Private Placement […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today resolved, with the approval of the Supervisory Board, to increase the Company’s share capital by up to EUR 3.9 million by issuing up to 3,855,694 new shares in order to finance the expansion of its commercialization activities, especially to the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
